about
siRNA delivery to the lung: what's new?Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding.Optimization of Polyplex Formation between DNA Oligonucleotide and Poly(ʟ-Lysine): Experimental Study and Modeling ApproachDynamics of nucleic acid/cationic polymer complexation and disassembly under biologically simulated conditions using in situ atomic force microscopy.Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNAGlioma cell growth inhibition following photochemical internalization enhanced non-viral PTEN gene transfection.Gene therapy strategies for the treatment of chronic viral hepatitis.Inhibition of influenza virus production in virus-infected mice by RNA interference.Surface immobilization of plasmid DNA with a cell-responsive tether for substrate-mediated gene deliveryTailoring the supramolecular structure of aminated polyrotaxanes toward enhanced cellular internalization.STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer CellsCytokine therapy for craniosynostosis.Hydrophobization and bioconjugation for enhanced siRNA delivery and targetingIn vivo delivery of nucleic acids via glycopolymer vehicles affords therapeutic infarct size reduction in vivoProtection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirusPoly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA deliveryDelivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesPolymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.Efficient gene delivery to human umbilical cord mesenchymal stem cells by cationized Porphyra yezoensis polysaccharide nanoparticles.Stimuli-responsive polymers in gene delivery.Antiviral applications of RNAi for coronavirus.RNAi for treating hepatitis B viral infection.Therapeutic angiogenesis as a potential future treatment strategy for erectile dysfunction.RNA interference and antiviral therapy.In Vivo GFP Knockdown by Cationic Nanogel-siRNA PolyplexesTumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.Targeted gene delivery to the lung.Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination.Polymeric vectors for ocular gene delivery.Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.Applications of nanoparticle systems in gene delivery and gene therapy.Experimental design, modeling and optimization of polyplex formation between DNA oligonucleotides and branched polyethylenimine.Lung epithelial binding peptide-linked high mobility group box-1 A box for lung epithelial cell-specific delivery of DNA.Investigating polymer thiolation in gene delivery.A guanidinylated bioreducible polymer as a novel gene carrier to the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.Molecular weight-dependent genetic information transfer with disulfide-linked polyethylenimine-based nonviral vectors.Dexamethasone conjugation to polyamidoamine dendrimers G1 and G2 for enhanced transfection efficiency with an anti-inflammatory effect.The box A domain of high mobility group box-1 protein as an efficient siRNA carrier with anti-inflammatory effects.
P2860
Q27022043-A0E4B7EB-80CA-45A5-8687-2C868A1D47B2Q30397703-EEADFC6D-A078-48FE-9FC5-9271C003D42FQ30496206-84C9B7A5-15EA-4AC0-B899-C1A62737BC91Q33839032-2DF072B5-04D3-467D-8762-A5EE329E0445Q34097275-EA006A81-7124-4147-8523-BC723B40E5A5Q34365466-DF2C5D64-10F1-4ABD-81A2-9B92F92E1504Q34423421-0FDBB3EA-FEE8-4E80-9093-B4B7DF322183Q34451890-6373F0BA-85D9-48C7-925E-ACDE8D22D8E6Q34514513-8A3D9486-1A01-4D99-8375-4EC4952802D9Q35041201-DCE3E50C-69C8-454F-8D9F-F34194E327B9Q35122198-50D6CCF8-BC81-41CB-A602-E1956EE00341Q35553333-97D104C5-739C-4C82-8F24-389CC4D71CD4Q35684846-A94F2FC7-B4EB-4731-A890-A89068C188C0Q35697443-337F07C9-70EC-4735-8018-DAC15378FB9FQ35802123-C9D5329F-6F34-48F2-A814-81D05362C69DQ35821087-B4A4AF66-A873-41FD-A937-87A0CB66AC32Q35828034-307E06B0-6AF8-4765-B1EE-809453EF2116Q35846835-D872045C-300A-42D4-AC65-34DEC5684A5AQ36014423-2C5A2408-1460-47B8-BF2B-EBC9DC94CD6BQ36307218-A7DF6B21-552F-4778-BEA0-DFB3BEE48DF3Q36315150-5C973802-A3A0-4483-A57F-A9FB8B847BE2Q36376425-FAC6B158-F036-44BB-91DA-BD6F98F4B2E4Q36412870-333A7950-C605-49E7-850E-F24179AC9A58Q36758130-E48F5130-43F1-4E27-A034-67BB3A9603BCQ36944914-426B2FFF-B6E9-4CAD-97B6-291FE8B45962Q36973296-F0437821-E972-45DF-B4DC-7C53B34DE73CQ37012358-BDA019CF-C9A4-4444-81F4-9883754E42BCQ37486747-9D8243EE-A6CA-4734-803A-EB390480FEB5Q37657507-97110E09-8F5F-4E09-B0FD-E443F381EED8Q37805248-27BC8C27-3EB0-4D68-92C4-02F2993CF9D0Q37920729-577F17F0-EDD2-4711-9E63-2F0DD45B9D59Q38161927-7ED215C7-8D9C-48F1-B54F-7A904FD0A717Q38264536-58A7562F-03FB-482E-9E5F-7524AE7BCA22Q38297233-676FBB8F-8FB8-4EBD-AA71-2748144F0C8DQ38337404-33863531-CF74-42A9-88FE-836047A2B39BQ39155824-539323D1-0415-4D92-AFF3-2FD2C7CB77F1Q39211208-D9F1487F-7B09-4D5B-BF8C-889D9366C801Q39296034-521E00E6-F9C4-4530-8C43-A33D71545013Q39305856-03FAC62C-A8A1-4131-BA13-CC82C911F553Q39478314-539F21BF-0ADE-44B8-8632-D87D5F35C4EB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of biomaterials for gene therapy.
@ast
Development of biomaterials for gene therapy.
@en
Development of biomaterials for gene therapy.
@nl
type
label
Development of biomaterials for gene therapy.
@ast
Development of biomaterials for gene therapy.
@en
Development of biomaterials for gene therapy.
@nl
prefLabel
Development of biomaterials for gene therapy.
@ast
Development of biomaterials for gene therapy.
@en
Development of biomaterials for gene therapy.
@nl
P2093
P356
P1433
P1476
Development of biomaterials for gene therapy.
@en
P2093
P304
P356
10.1006/MTHE.2000.0142
P577
2000-10-01T00:00:00Z